<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>EAPSI:  Microfabricated Heparin Hydrogels for Liver Tissue Engineering</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>06/01/2010</AwardEffectiveDate>
<AwardExpirationDate>05/31/2011</AwardExpirationDate>
<AwardTotalIntnAmount>5617.00</AwardTotalIntnAmount>
<AwardAmount>5617</AwardAmount>
<AwardInstrument>
<Value>Fellowship Award</Value>
</AwardInstrument>
<Organization>
<Code>01090000</Code>
<Directorate>
<Abbreviation>O/D</Abbreviation>
<LongName>Office Of The Director</LongName>
</Directorate>
<Division>
<Abbreviation>OISE</Abbreviation>
<LongName>Office Of Internatl Science &amp;Engineering</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Anne Emig</SignBlockName>
<PO_EMAI>aemig@nsf.gov</PO_EMAI>
<PO_PHON>7032927241</PO_PHON>
</ProgramOfficer>
<AbstractNarration/>
<MinAmdLetterDate>06/01/2010</MinAmdLetterDate>
<MaxAmdLetterDate>06/01/2010</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.079</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>1015124</AwardID>
<Investigator>
<FirstName>Sunny</FirstName>
<LastName>Shah</LastName>
<PI_MID_INIT>S</PI_MID_INIT>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Sunny S Shah</PI_FULL_NAME>
<EmailAddress/>
<PI_PHON>5746312566</PI_PHON>
<NSF_ID>000549826</NSF_ID>
<StartDate>06/01/2010</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Shah                    Sunny          S</Name>
<CityName>Davis</CityName>
<ZipCode>956160159</ZipCode>
<PhoneNumber/>
<StreetAddress/>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<StateCode>CA</StateCode>
<CONGRESSDISTRICT>03</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>CA03</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM/>
<ORG_LGL_BUS_NAME/>
<ORG_PRNT_DUNS_NUM/>
</Institution>
<Performance_Institution>
<Name><![CDATA[Shah                    Sunny          S]]></Name>
<CityName>Davis</CityName>
<StateCode>CA</StateCode>
<ZipCode>956160159</ZipCode>
<StreetAddress/>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>California</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>03</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>CA03</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<ProgramElement>
<Code>7316</Code>
<Text>EAPSI</Text>
</ProgramElement>
<ProgramReference>
<Code>5942</Code>
<Text>KOREA</Text>
</ProgramReference>
<ProgramReference>
<Code>5978</Code>
<Text>EAST ASIA AND PACIFIC PROGRAM</Text>
</ProgramReference>
<ProgramReference>
<Code>7316</Code>
<Text>EAPSI</Text>
</ProgramReference>
<Appropriation>
<Code>0110</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2010~5617</FUND_OBLG>
<POR>
<DRECONTENT><![CDATA[<div class="porColContainerWBG"> <div class="porContentCol"><p>The liver has a central role in metabolic homeostasis and is the main detoxifying organ of the body.&nbsp; In extreme cases of liver dysfunction, there is a need for supply of healthy liver cells, or hepatocytes.&nbsp; The goal of the research in Korea was to develop a platform consisting of bioactive heparin-based hydrogel followed by successful culturing of liver cells. In the future, this platform will be used to grow liver cells and then implant them inside dysfunctional liver. Research was carried out at Dr. Giyoong Tae&rsquo;s laboratory in Gwangju Institute of Science and Technology (GIST) in Gwangju, South Korea. Dr. Tae started working with hydrogels during his doctoral work in 1996 and is now a leading expert in heparin-based hydrogels thus providing an ideal research environment to conduct the proposed studies.</p> <p>The main objective of the project was to develop a technique where liver cells can be selectively grown on top of heparin-hydrogel micropatterns. These cell-containing hydrogel micropellets can then be released from the surface and used for future implantation studies. We employed a series of surface science experiments to find an optimal protocol to selectively attach cells only on top of these bioactive hydrogel micropatterns. First, photolithography was used to make micropatterns of heparin hydrogel on a glass substrate (Figure 1). To prevent cells from attaching in the neighboring regions, they were modified with a molecule (PEG-thiol) that would prevent adhesion of cells. Finally, the surface was incubated with a protein that attached selectively to the hydrogels and allowed cells to attach (Figure 2). We were also able to show that cells can be cultured for six days on top of the hydrogel. Immunostaining experiments showed that the cells were producing albumin which is a liver hallmark protein indicating that the cells were healthy and functional.</p> <p>Hepatic tissue engineering is an important area of research because of the severe liver donor shortage, high cost, and complexity of orthotropic liver transplantation. This proposal will lay the foundation for future research in liver tissue engineering and its ability to provide a viable source of liver cells for cell therapy applications. In addition to academic impact, the conducted research also had a significant educational impact.&nbsp; The knowledge on heparin hydrogels and its ability to maintain functionality of liver cells was used as teaching material in an undergraduate biomaterials class. After completion of the project, I continued to mentor two undergraduate students to work on culturing of cells on heparin-based hydrogel.</p> <p>My project at GIST laid the foundation for future collaborative efforts between the two countries. My major advisor, Dr. Alexander Revzin, completed a sabbatical at GIST further exploring the applications of heparin hydrogels in tissue engineering. Our lab has published one paper and is in the process of submitting another journal article after completion of my project in Korea. Finally, we have also established collaborations at other leading Korean institutions such as Yonsei Unversity and Postech.</p> <p>&nbsp;</p><br> <p>            Last Modified: 07/07/2011<br>      Modified by: Sunny&nbsp;S&nbsp;Shah</p> </div> <div class="porSideCol"> <div class="each-gallery"> <div class="galContent" id="gallery0"> <div class="photoCount" id="photoCount0">          Images (<span id="selectedPhoto0">1</span> of <span class="totalNumber"></span>)           </div> <div class="galControls" id="controls0"></div> <div class="galSlideshow" id="slideshow0"></div> <div class="galEmbox" id="embox"> <div class="image-title"></div> </div> </div> <div class="galNavigation" id="navigation0"> <ul class="thumbs" id="thumbs0"> <li> <a href="/por/images/Reports/POR/2011/1015124/1015124_10016576_1310060538573_Untitled--rgov-214x142.jpg" original="/por/images/Reports/POR/2...]]></DRECONTENT>
<POR_COPY_TXT><![CDATA[ The liver has a central role in metabolic homeostasis and is the main detoxifying organ of the body.  In extreme cases of liver dysfunction, there is a need for supply of healthy liver cells, or hepatocytes.  The goal of the research in Korea was to develop a platform consisting of bioactive heparin-based hydrogel followed by successful culturing of liver cells. In the future, this platform will be used to grow liver cells and then implant them inside dysfunctional liver. Research was carried out at Dr. Giyoong TaeÃ†s laboratory in Gwangju Institute of Science and Technology (GIST) in Gwangju, South Korea. Dr. Tae started working with hydrogels during his doctoral work in 1996 and is now a leading expert in heparin-based hydrogels thus providing an ideal research environment to conduct the proposed studies.  The main objective of the project was to develop a technique where liver cells can be selectively grown on top of heparin-hydrogel micropatterns. These cell-containing hydrogel micropellets can then be released from the surface and used for future implantation studies. We employed a series of surface science experiments to find an optimal protocol to selectively attach cells only on top of these bioactive hydrogel micropatterns. First, photolithography was used to make micropatterns of heparin hydrogel on a glass substrate (Figure 1). To prevent cells from attaching in the neighboring regions, they were modified with a molecule (PEG-thiol) that would prevent adhesion of cells. Finally, the surface was incubated with a protein that attached selectively to the hydrogels and allowed cells to attach (Figure 2). We were also able to show that cells can be cultured for six days on top of the hydrogel. Immunostaining experiments showed that the cells were producing albumin which is a liver hallmark protein indicating that the cells were healthy and functional.  Hepatic tissue engineering is an important area of research because of the severe liver donor shortage, high cost, and complexity of orthotropic liver transplantation. This proposal will lay the foundation for future research in liver tissue engineering and its ability to provide a viable source of liver cells for cell therapy applications. In addition to academic impact, the conducted research also had a significant educational impact.  The knowledge on heparin hydrogels and its ability to maintain functionality of liver cells was used as teaching material in an undergraduate biomaterials class. After completion of the project, I continued to mentor two undergraduate students to work on culturing of cells on heparin-based hydrogel.  My project at GIST laid the foundation for future collaborative efforts between the two countries. My major advisor, Dr. Alexander Revzin, completed a sabbatical at GIST further exploring the applications of heparin hydrogels in tissue engineering. Our lab has published one paper and is in the process of submitting another journal article after completion of my project in Korea. Finally, we have also established collaborations at other leading Korean institutions such as Yonsei Unversity and Postech.          Last Modified: 07/07/2011       Submitted by: Sunny S Shah]]></POR_COPY_TXT>
</POR>
</Award>
</rootTag>
